Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease
- PMID: 20522863
- DOI: 10.1136/thx.2009.133173
Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease
Abstract
Guidelines have been compiled by the Joint Tuberculosis Committee of the British Thoracic Society for the prevention and management of Mycobacterium tuberculosis infection and disease in patients with all grades of renal impairment.
Comment in
-
A comparison between interferon gamma release assays and the tuberculin skin test in the contact tracing of patients with chronic kidney disease.Thorax. 2011 Aug;66(8):729-30; author reply 730. doi: 10.1136/thx.2010.149088. Epub 2010 Oct 14. Thorax. 2011. PMID: 20947898 No abstract available.
Similar articles
-
An update on the management of latent tuberculosis infection and active disease in patients with chronic kidney disease.Pol Arch Intern Med. 2017 Aug 24;127(10):681-686. doi: 10.20452/pamw.4093. Epub 2017 Aug 24. Pol Arch Intern Med. 2017. PMID: 28837544 Review.
-
Tuberculosis and chronic kidney disease: an emerging global syndemic.Kidney Int. 2016 Jul;90(1):34-40. doi: 10.1016/j.kint.2016.01.034. Epub 2016 May 10. Kidney Int. 2016. PMID: 27178832 Review.
-
[Who must have tuberculosis screening? Characteristics of risk patients].MMW Fortschr Med. 2013 May 16;155(9):16-8. MMW Fortschr Med. 2013. PMID: 23951641 German. No abstract available.
-
Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis.Pediatr Infect Dis J. 2014 Jun;33(6):664-6. doi: 10.1097/INF.0000000000000260. Pediatr Infect Dis J. 2014. PMID: 24445837
-
[Tuberculosis and nontuberculous mycobacterial infections].Dtsch Med Wochenschr. 2011 Apr;136(14):691-4. doi: 10.1055/s-0031-1274565. Epub 2011 Mar 29. Dtsch Med Wochenschr. 2011. PMID: 21448828 Review. German. No abstract available.
Cited by
-
Tuberculosis in kidney transplant candidates and recipients.World J Transplant. 2024 Sep 18;14(3):96225. doi: 10.5500/wjt.v14.i3.96225. World J Transplant. 2024. PMID: 39295970 Free PMC article. Review.
-
Effect of chronic kidney disease on adverse drug reactions to anti-tubercular treatment: a retrospective cohort study.Ren Fail. 2024 Dec;46(2):2392883. doi: 10.1080/0886022X.2024.2392883. Epub 2024 Aug 21. Ren Fail. 2024. PMID: 39165235 Free PMC article.
-
Analysis of the clinical characteristics of 100 patients who developed tuberculosis after renal transplantation.BMC Infect Dis. 2025 Jun 4;25(1):795. doi: 10.1186/s12879-025-11197-7. BMC Infect Dis. 2025. PMID: 40468201 Free PMC article.
-
[Modern antituberculosis treatment].Internist (Berl). 2013 May;54(5):630-8. doi: 10.1007/s00108-013-3244-5. Internist (Berl). 2013. PMID: 23529718 Review. German.
-
Role of interferon-gamma release assay for screening and monitoring of latent tuberculosis infection in kidney transplant recipients.BMC Infect Dis. 2024 Oct 7;24(1):1110. doi: 10.1186/s12879-024-09990-x. BMC Infect Dis. 2024. PMID: 39375585 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical